Loading
Cawachi Limited: what insiders have been doing
Only a handful of insider records exist for Cawachi Limited, the last one from 10 June 2026, too few to describe a trend. This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,424 of 26,289 companies
48.6
score / 100
Value58
Quality39
FCF yld5.1%
Earn yld3.6%
EV/EBITDA10.3x
ROE2.9%
Gross mgn23%
Net mgn1.1%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥3,760
Analyst consensus
Income statement
RevenueJP¥284.5B
Gross profitJP¥65.3B23% margin
EBITDAJP¥10.1B4% margin
Net incomeJP¥3.2B1.1% margin
Valuation
PER (trailing)26.3x
P/Book0.7x
Beta0.17
Balance sheet & cash
Market capJP¥82.3B
Total debtJP¥16.1B
Free Cash FlowJP¥4.5B
Debt / Equity14%
Profitability & ownership
ROE2.9%
ROA2.1%
% insiders39.7%
% institutions16.2%
Last declaration on 10 June 2026
Declarations1 total
100.0% of flowShareXTKSEDINET:S100YABZ
1 of 1 declaration
About Cawachi Limited
Kawachi Drugstore Co., Ltd. is a Japanese company specializing in the sale of pharmaceutical and health products. It primarily operates in the market for the distribution of medicines and health-related consumer goods.
